Specifications
- Assay duration:Multiple steps
- Assay Type (ELISA with LOV):Sandwich
- Format:Pre-coated
- Primary antibody reactivity:Human
- Target protein:Fibrinogen beta Chain
- Description:Human fibrinogen beta chain ELISA kit
- Size:96 tests
- Sample Type:Serum, plasma, tissue homogenates and other biological fluids
- Cross Reactivity:Human Fibrinogen beta Chain ELISA kit exhibits high specificity and excellent specificity for the detection of human Fibrinogen beta Chain. No significant cross-reactivity or interference between Fibrinogen beta Chain and analogues was observed.
- Detection Method:Colorimetric
- Time to Results:4 h 30 min
- Assay Principle:Quantitative
- Shelf Life:Store for 6 months at 4 °C
- Detection Range:0.469 - 30 ng/ml
- Storage Temperature:4 °C
- Sample Volume:100 μl
- Sensitivity:0.281 ng/ml
- Regulatory Status:RUO
- Cat. No.:76744-486
Specifications
About this item
Human Fibrinogen beta Chain ELISA kit is a sandwich Enzyme-Linked Immunosorbent Assay (sELISA) designed for the in vitro quantitative determination of human Fibrinogen beta Chain in serum, plasma, tissue homogenates, and other biological fluids.
- Ready to use ELISA kit
- Detection range: 0.469 to 30 ng/ml
- Sensitivity: 0.281 ng/ml
- Sample type: Serum, plasma, tissue homogenates, and other biological fluids
- Assay precision: Intra assay: CV <8%, Inter assay: CV <10%
Human Fibrinogen beta Chain ELISA kit (A78089) employs the sandwich enzyme immunoassay technique for the quantitative measurement of human Fibrinogen beta Chain in serum, plasma, tissue homogenates, and other biological fluids. An antibody specific for Fibrinogen beta Chain has been pre-coated onto a 96-well microtiter plate. The standards and test samples are added into the wells and the Fibrinogen beta Chain present in each sample is bound to the wells by the immobilized antibody. Following incubation, the wells are washed and then incubated with Biotinylated Anti-Fibrinogen beta Chain Antibody, which binds the captured Fibrinogen beta Chain present in each well. Following incubation, unbound biotinylated detection antibody is removed by washing, and an HRP-Streptavidin conjugate is added to the wells and the microtiter plate is incubated. Following incubation and washing, TMB substrate solution is then used to visualize the HRP enzymatic reaction by catalysis to produce a blue-coloured product that changes to yellow after addition of acidic stop solution. The density of yellow is proportional to the amount of Fibrinogen beta Chain captured in each well. The concentration of Fibrinogen beta Chain can then be calculated by reading the O.D. absorbance at 450 nm in a microplate reader and referring to the standard curve.